Results for the Financial Year Ended 31st March 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Deccan Health Care Limited reported FY25 standalone revenue from operations of Rs 7,513.19 lakhs, up about 25.8% from Rs 5,972.89 lakhs in FY24. However, profit after tax fell to Rs 119.79 lakhs from Rs 152.17 lakhs, a decline of roughly 21%, as expenses (especially raw materials and other expenses) grew faster than revenue. EPS basic dropped to Rs 0.56 from Rs 0.82. Consolidated revenue grew to Rs 7,505.79 lakhs with PAT of Rs 115.87 lakhs. The auditor (Keyur Shah & Associates) issued an unmodified (clean) opinion on both standalone and consolidated results. The company raised Rs 331.80 lakhs from warrant holders during the quarter and allotted 7,59,666 equity shares. Operating cash flow remained negative for the second year in a row at around Rs (660) lakhs standalone.
Strong top-line growth signals expanding business, but the sharp PAT decline and continued negative operating cash flow may concern investors. Share dilution from warrant conversions is modest, and the clean audit opinion is a positive, though profitability and cash conversion remain areas to watch.